Add like
Add dislike
Add to saved papers

MicroRNA 34a contributes to virus-mediated apoptosis through binding to its target gene Bax in influenza A virus infection.

OBJECTIVE: Influenza A virus is a cytolytic virus that induces apoptosis in numerous cell types. However, molecular mechanism of cell apoptosis induced by influenza A virus is not well understood. The present study was aimed to investigate the molecular mechanism of miR-34a involved in influenza A virus induced apoptosis.

METHODS: Firstly, microRNA array was used to select miRNAs involved in influenza A virus infection. Then, Luciferase reporter assay and western blot were carried to determine the target gene of miR-34a. Finally, miR-34a mimic was transfected in influenza A virus-infected A549 cells, and western blot was used to test the function of miR-34a and its target gene in in influenza A virus infection.

RESULTS: miR-34a was found significantly down-regulated in influenza A virus-infected A549 cells and was further confirmed by qRT-PCR in vitro and in vivo (P<0.01). Next, transfection miR-34 mimic/inhibitor in influenza A virus-infected A549 cells showed that overexpression of miR-34a could inhibit influenza virus-induced apoptosis. Furthermore, target prediction analysis revealed that miR-34a complemented to the 3'-UTR of Bax mRNA. Luciferase reporter assay and western blot confirm that miR-34a directly targeted Bax. Moreover, we detected influenza virus infection enhanced the luciferase reporter translational activity in A549 cells transfected with the construct with Bax 3'-UTR encoding miR-34a binding site. However, western blot analysis showed that the up-regulation of Bax protein level was significantly reversed by overexpression miR-34a.

CONCLUSION: It is, therefore, concluded that influenza virus infection regulated pro-apoptotic Bax expression through miR-34a downregulation, which might be the partial mechanism of influenza virus-induced cell apoptosis.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app